>Year 2017, Issue 2
Menchaca RLG, Larios FMC, Garza MRA
Gastric bypass as a metabolic management model in type 2 diabetes mellitus and obesity grade 1, compared to conventional treatment
Cir Gen 2017; 39 (2)
PDF: 4. Kb.
Background: Type 2 diabetes (DM2) is a public health problem worldwide. In 1994 Pories reported glycemic correction after gastric bypass in obese patients with DM2; then, Rubino, Scopinaro (2002) and Carbajo (2008) confirmed this glycemic normalization during the first postoperative week. Studies in patients submitted to gastrojejunal surgery due to peptic acid disease or neoplasms reported similar results in blood glucose control. The American Diabetes Association justifies this procedure to be performed under protocol study in patients with BMI between 30 and 35. Material and methods: A non-blind experimental cohort study; 47 patients with type 2 diabetes and grade I obesity were selected at the High Specialty Regional Monterrey Hospital, ISSSTE; 13 patients (cases) underwent gastric bypass and were compared versus 34 patients in conventional clinical treatment (control) in one-year follow-up. Results: The 13 patients who underwent surgery (eight female and five male) started with a mean HbA1c = 9.7%, which decreased to 6% post-surgery. Only three of them continue with oral hypoglycemic agents in minimal doses. Regarding the 34 clinical treatment patients, their initial (2015) mean HbA1c = 9.2%, and their 2016 mean = 8.9%, maintaining medications. Discussion: The control group had a high risk of complications. Gastric bypass showed to be more effective in the control of HbA1c. Conclusions: Patients with DM2 and BMI between 30 and 35 are a highly vulnerable group, which should be included in bariatric surgical procedures to avoid complications with irreparable damage.
||Gastric bypass, metabolic surgery, obesity, diabetes.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21: 1414-1431.
Aguilar-Salinas CA, Velazquez-Monroy O, Gómez-Pérez FJ, Gonzalez-Chávez A, Esqueda AL, Molina-Cuevas V et al. Characteristics of patients with type 2 diabetes in Mexico: results from a large population-based nationwide survey. Diabetes Care. 2003; 26: 2021-2026.
Encuesta Nacional de Salud y Nutrición de Medio Camino 2016 (ENSANUT 2016). Instituto Nacional de Salud Pública. p. 46. Disponible en: http://www.epidemiologia.salud.gob.mx/doctos/encuestas/resultados/ENSANUT.pdf
American Diabetes Association (ADA). 2017. Disponible en: http://professional.diabetes.org/sites/professional.diabetes.org/files/media/dc_40_s1_final.pdf
American Diabetes Association. Standards of medical care in diabetes 2010. Diabetes Care. 2010; 33 Suppl 1: S11-S61.
Unger J. Diagnosis and management of type 2 diabetes and prediabetes. Prim Care. 2007; 34: 731-59, vi.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553.
Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222: 339-350; discussion 350-352.
Pories WJ. Diabetes: the evolution of a new paradigm. Ann Surg. 2004; 239: 12-13.
Scopinaro N, Papadia F, Camerini G, Marinari G, Civalleri D, Gian Franco A. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008; 18: 1035-1038.
Carbajo MA, Ortiz de SJ, García-Lanza C, Pérez MM, Fonseca OG, Castro MJ. Bypass gástrico laparoscópico de una sola anastomosis (BAGUA) asistido con brazo robótico: Técnica y resultados en 1,126 pacientes. Rev Mex Cir Endoscop. 2008; 9: 6-13.
Cerón-Rodríguez F, Márquez-González SM, Ampudia-Chávez JD, Zúñiga-García Y, Valdés-Sánchez AP, Zubirán-Moreno JM, et al. Bypass gástrico López Mateos. Descripción de la técnica. Rev Mex Cir Endoscop. 2014; 15: 6-9.
Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006; 244: 741-749.
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002; 236: 554-559.
Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004; 240: 236-242.
Pinheiro JS, Schiavon CA, Pereira PB, Correa JL, Noujaim P, Cohen R. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis. 2008; 4: 521-525; discussion 526-527.
Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008; 31 Suppl 2: S290-S296.
Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Lopez-Jimenez F. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008; 83: 897-907.
Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008; 93: S89-S96.
Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007; 107: 1755-1767.
Jayasena CN, Bloom SR. Role of gut hormones in obesity. Endocrinol Metab Clin North Am. 2008; 37: 769-787, xi.
Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg. 1998; 227: 637-643; discussion 643-644.
Moo TA, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008; 15: 153-158.
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122: 248-256.e5.
Thaler JP, Cummings DE. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009; 150: 2518-2525.
MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997; 1: 213-220; discussion 220.
Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond). 2009; 33 Suppl 1: S33-S40.
Folli F, Pontiroli AE, Schwesinger WH. Metabolic aspects of bariatric surgery. Med Clin North Am. 2007; 91: 393-414.
Paula-Meyer M. Gastric bypass surgery patients at high risk of complications. Medscape. 2003.
Dixon J. Survival advantage with bariatric surgery: Report from the 10th International Congress on Obesity. Surg Obes Relat Dis. 2006; 2: 585-586.
Norma Oficial Mexicana NOM-008-SSA3-2010, Para el tratamiento integral del sobrepeso y la obesidad.
Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004; 239: 1-11.
Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg. 2008; 12: 945-952.
DePaula AL, Macedo AL, Rassi N, Machado CA, Schraibman V, Silva LQ, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008; 22: 706-716.
Cohen R. Gastrointestinal surgery for non-obese diabetics type 2. Rev Med Clin Condes. 2009; 20: 698-702.
>Year 2017, Issue 2